Postherpetic neuralgia

Acta Clinica Croatica

Volumn 46, Issue 3, 2007, Pages 279-282

  Bašić Kes, Vanja ^a   Demarin, Vida ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Herpes zoster drug therapy; Herpes zoster physiopathology; Neuralgia drug therapy; Neuralgia etiology; Neuralgia physiopathology; Pain etiology

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUPIVACAINE; CAPSAICIN; DESIPRAMINE; DEXTROMETHORPHAN; GABAPENTIN; IMIPRAMINE; KETAMINE; LIDOCAINE; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORTRIPTYLINE; OPIATE; PREGABALIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUPUNCTURE; ANTICHOLINERGIC EFFECT; BEDTIME DOSAGE; BLURRED VISION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EVIDENCE BASED MEDICINE; HEART MUSCLE CONDUCTION DISTURBANCE; HERPES ZOSTER; HUMAN; LIVER TOXICITY; LOW DRUG DOSE; MEMORY DISORDER; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; POSTHERPETIC NEURALGIA; REVIEW; SEDATION; SIDE EFFECT; THROMBOCYTOPENIA; TRANSCUTANEOUS NERVE STIMULATION; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT; URINE RETENTION; XEROSTOMIA;

EID: 37049033273     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. GLYNN C, CROCKFORD G, GAVAGHAN D. Epidemiology of shingles. J R Soc Med 1990;83:617-9.
2. JUNG BF, JOHNSON RW, GRIFFIN DR, DWORKIN RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004;62:1545-51.
3. DWORKIN RH, BOON RJ, GRIFFIN DR, PHUNG D. Postherpetic neuralgia: impact of famcilclovir, age, rash severity and acute pain in herpes zoster patients. J Infect Dis 1998; 178:S76-80.
4. DWORKIN RH, PORTENOY RK. Pain and its persistence in herpes zoster. Pain 1996;67:241-51.
5. DONAHUE JG, CHOO PW, MANSON JE, PLATT R. The incidence of herpes zoster. Arch Intern Med 1995;155:1605-9.
6. BARON R, WASNER G. Prevention and treatment of postherpetic neuralgia. Lancet 2006;367:186-8.
7. BOWSHER D. Pathophysiology of postherpetic neuralgia: towards a rational treatment. Neurology 1995;45:S56-7.
8. NURMIKKO T. Clinical features and pathophysiologic mechanisms of postherpetic neuralgia. Neurology 1995;45(12 Suppl 8):S54-5.
9. HEMPENSTALL K, NURMIKKO TJ, JOHNSON RW, A'HERN RP, RICE AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLos Med 2005; 2(7):e 164.
10. ROWBOTHAM MC, DAVIES PS, VERKEMPINCK C, GALER BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44.
11. DUBINSKY RM, KABBANI H, El-CHAMI Z. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63:959-65.
12. SWERDLOW M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 1984;7:51-82.
13. EIDE P, JORUM E, STUBHAUG A. Relief of postherpetic neuralgia with NMDA receptor antagonist ketamine: a double-blind, crossover comparison with morphine and placebo. Pain 1994;58:347-54.
14. RICE AS, MATON S. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain 2001;94:215-24.
15. DWORKIN RH, CORBIN AE, YOUNG JP. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo controlled trial. Neurology 2003;60:1274-83.
16. KOTANI N, KUSHIKATA T HASHIMOTO H. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000;343:1514-9.
17. ALPER BS, LEWIS PR. Treatment of postherpetic neuralgia: a systematic review of the literature. J Fam Pract 2002;51:121-8.